Globe Life Inc. (NYSE:GL) Given Average Recommendation of “Moderate Buy” by Analysts

Globe Life Inc. (NYSE:GL) has received a consensus rating of “Moderate Buy” from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $175.8889.

Several equities research analysts have recently weighed in on GL shares. Morgan Stanley upped their target price on shares of Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, May 21st. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. TD Cowen boosted their price target on shares of Globe Life from $199.00 to $215.00 and gave the company a “buy” rating in a research report on Tuesday, June 23rd. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. Finally, Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th.

Insider Buying and Selling at Globe Life

In related news, CEO James Matthew Darden sold 4,663 shares of the firm’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the completion of the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $8,994,439.88. This trade represents a 7.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director directly owned 16,621 shares of the company’s stock, valued at $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 124,187 shares of company stock worth $19,529,414 over the last 90 days. Company insiders own 2.11% of the company’s stock.

Institutional Trading of Globe Life

A number of hedge funds and other institutional investors have recently made changes to their positions in GL. SG Americas Securities LLC lifted its position in Globe Life by 909.6% during the 4th quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock worth $13,950,000 after buying an additional 89,866 shares in the last quarter. Tudor Investment Corp ET AL acquired a new stake in Globe Life in the 3rd quarter valued at about $7,348,000. JPMorgan Chase & Co. increased its position in Globe Life by 11.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 247,947 shares of the company’s stock valued at $35,449,000 after acquiring an additional 24,785 shares in the last quarter. Capitolis Liquid Global Markets LLC bought a new position in shares of Globe Life in the third quarter worth about $5,862,000. Finally, Magnetar Financial LLC raised its stake in shares of Globe Life by 2,185.8% in the third quarter. Magnetar Financial LLC now owns 40,435 shares of the company’s stock worth $5,781,000 after acquiring an additional 38,666 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Price Performance

Shares of GL stock opened at $180.47 on Friday. The stock’s fifty day simple moving average is $161.20 and its 200 day simple moving average is $148.85. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a market cap of $14.01 billion, a price-to-earnings ratio of 12.48 and a beta of 0.47. Globe Life has a one year low of $116.73 and a one year high of $182.32.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the company earned $3.07 earnings per share. The business’s revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, analysts expect that Globe Life will post 15.64 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is presently 9.13%.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.